Etripamil

CAS: 1593673-23-4

Ref. 3D-TNC67323

Produktinformation

• Name: Etripamil

Beschreibung

Etripamil is a pharmaceutical formulation that is administered by nasal administration. It is used to terminate supraventricular tachycardias with reentry in patients who are ambulatory, and it may be used for long-term treatment of atrioventricular (AV) blocks. Etripamil has been shown to increase the duration of refractory periods in patients with AV block, and it can be used as a diagnostic agent for AV blocks. Etripamil has been shown to have l-type calcium channel blocking effects, which may lead to termination of supraventricular tachycardia.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 452.6 g/mol
• Formel: C₂₇H₃₆N₂O₄
• Reinheit: Min. 95%